Reduce Your Supply Chain Risk with Proteomix POR-Q/S: Reliable Resins for IEX
.png)
Presented by Felder Martin Business Development Manager
The Proteomix POR-Q/S product line from Sepax Bioscience provides an alternative to other strong anion/cation exchange process chromatography resins on the market. Featuring a monodispersed PS/DVB matrix with trimethylamine (Q) or sulfonic acid (S) functional groups, these resins deliver high resolution and reliable performance for diverse bioprocessing applications.
In this webinar, we’ll provide product specifications compared to Cytiva’s Source® resins and share case studies on oligonucleotide purification, insulin purification and separating empty and full AAV capsids during AAV polishing. We’ll also discuss how Sepax’s secure supply chain and fast lead times can strengthen your supply chain resiliency and bioprocess operations.
Speaker Bio
Felder Martin is the Business Development Manager at Sepax Bioscience. She holds a Master’s degree in Biomanufacturing and Bioprocessing and a Bachelor’s degree in Microbiology from the University of Georgia, along with graduate certificates in International Biomedical Regulatory Science and Entrepreneurship.
Based in Durham, North Carolina, Felder has hands-on experience in chromatography resin applications from her previous role as an Application Scientist at JSR Life Sciences. She is dedicated to helping biopharmaceutical companies optimize their downstream bioprocess purification.
Innovative Contamination Control in Cell Therapy: Enabling Integrity and Efficiency
Presented by George Prout and Suzy Brown
Effective contamination control is essential for maintaining the integrity and quality of cell therapy manufacturing. This presentation will discuss the use of upstream solutions such as automated closed systems for isolation and activation, and larger bioprocess containers. It will also cover the application of analytical assays for sterility testing, mycoplasma detection, and environmental monitoring. These measures aim to reduce contamination and improve overall operational effectiveness. An integrated approach combining these solutions can enhance contamination control, boost process efficiency, and ensure the production of high-quality cell therapy products.
Learning Objectives:
- Learn about the role of automated closed systems and large bioprocess containers in preserving the integrity of cell therapy products.
- Discover the benefits of rapid analytical assays for reliable and accurate contamination detection.
- Consider how an integrated approach can enhance overall process efficiency and ensure high-quality outcomes.
Speaker Bio
George Prout – Field Application Scientist
George Prout is an Application Scientist at Thermo Fisher Scientific covering Cell Culture and Cell Therapy. His role involves technical support with customers wanting to drive higher output of their systems and actively looks for collaborations with fellow scientists in disciplines such as protein production, plasmid production, vaccines, cultured meat, microbial processes, gene therapy and cell therapy from research, to process development and scale-up. George has 8 years of experience in Gene Therapy prior to joining Thermo Fisher Scientific, with a focus on manufacturing, process development and project management.
Suzy Brown - Senior Field Application Scientist
Suzy Brown is the Senior Field Application Scientist for Pharma Analytics, supporting customers in the UK and Ireland. She has been with Thermo Fisher Scientific for 8 years where she provides training and implementation of the Pharma Analytics portfolio. During this time, she has taken on the role of MycoSEQ subject matter expert for the EMEA region.
Suzy gained a Cell Biology Degree, and later a Developmental Biology PhD at the University of Manchester (UK) where she applied molecular, proteomic and Next Generation Sequencing approaches to identify genes required for pattern formation in model organism Dictyostelium discoideum development. Following university, Suzy moved into the Biopharmaceutical Industry and worked as an Analytical Development Scientist for 3 years at Allergan Biologics, within a Molecular Biology team and has experience in qPCR, Sanger Sequencing and impurity testing.